ARP Americas LP purchased a new position in shares of Aetna Inc (NYSE:AET) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 42,094 shares of the company’s stock, valued at approximately $7,593,000. Aetna makes up about 2.2% of ARP Americas LP’s investment portfolio, making the stock its 2nd largest holding.
A number of other large investors have also recently added to or reduced their stakes in AET. Alpine Associates Management Inc. acquired a new position in Aetna during the fourth quarter worth $159,933,000. Orbimed Advisors LLC increased its position in shares of Aetna by 57.3% during the third quarter. Orbimed Advisors LLC now owns 1,396,500 shares of the company’s stock worth $222,057,000 after acquiring an additional 508,600 shares during the period. CI Investments Inc. purchased a new stake in shares of Aetna during the fourth quarter worth $87,552,000. Governors Lane LP purchased a new stake in shares of Aetna during the fourth quarter worth $68,223,000. Finally, Point72 Asset Management L.P. increased its position in shares of Aetna by 233.9% during the third quarter. Point72 Asset Management L.P. now owns 429,353 shares of the company’s stock worth $68,271,000 after acquiring an additional 300,753 shares during the period. Institutional investors own 87.10% of the company’s stock.
A number of research firms have recently weighed in on AET. ValuEngine raised Aetna from a “hold” rating to a “buy” rating in a research report on Friday, February 2nd. Piper Jaffray Companies reaffirmed a “buy” rating and set a $212.00 price objective on shares of Aetna in a research report on Tuesday, January 30th. Citigroup lowered Aetna from a “buy” rating to a “neutral” rating and upped their price objective for the stock from $187.89 to $212.00 in a research report on Wednesday, January 31st. Credit Suisse Group upped their price objective on Aetna from $200.00 to $208.00 and gave the stock a “neutral” rating in a research report on Wednesday, January 31st. Finally, Cowen reaffirmed a “buy” rating and set a $212.00 price objective on shares of Aetna in a research report on Tuesday, January 30th. Ten analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. Aetna presently has an average rating of “Buy” and a consensus target price of $185.94.
Aetna (NYSE:AET) last posted its earnings results on Tuesday, January 30th. The company reported $1.25 EPS for the quarter, beating the consensus estimate of $1.18 by $0.07. The firm had revenue of $14.74 billion for the quarter, compared to analyst estimates of $14.79 billion. Aetna had a return on equity of 21.50% and a net margin of 3.15%. Aetna’s revenue for the quarter was down 6.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.08 earnings per share. equities analysts expect that Aetna Inc will post 10.99 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Friday, January 26th. Investors of record on Thursday, January 11th were issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 1.12%. The ex-dividend date was Wednesday, January 10th. Aetna’s dividend payout ratio (DPR) is presently 33.06%.
ILLEGAL ACTIVITY WARNING: This story was first reported by Community Financial News and is the property of of Community Financial News. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of US & international copyright legislation. The correct version of this story can be read at https://www.com-unik.info/2018/02/19/42094-shares-in-aetna-inc-aet-purchased-by-arp-americas-lp.html.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.